TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-02-15
公報種別公開国際商標公報
国際登録番号1694412
国際登録日
区分第5類(薬剤)
商品役務Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders全 27 件を表示, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.
基礎出願番号97368281
基礎出願日2022-04-18
基礎出願国US
出願人Sarepta Therapeutics, Inc.
OCRテキストALDYSTRO
OCRテキスト2ALDYSTRO
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

Novo Nordisk A/S
Zembrilio
2日前
Novo Nordisk A/S
Zilconyc
2日前
Alcon Inc.
TRIPTYR
1か月前
Alcon Inc.
TRYPTYR
1か月前
MP ACQUISITION CORP.
COMBAT
3か月前
Regenexx, LLC
Regenex*
23日前
Minch Global Trade Inc.
Beworths
23日前
Brexogen Inc.
PetBEX
23日前
F. Hoffmann-La Roche AG
GESERDLI
23日前
F. Hoffmann-La Roche AG
YASERD
23日前
BioAtlantis Limited
ENDOPRIME PRIMINGENDOCRINEFUNCTIONFOROPTIMALHEALTH
23日前
Nanjing Abhasvara Therapeutics Co., Ltd.
ABHASVARA
23日前
XENON PHARMACEUTICALS INC.
EPKEYO
23日前
Pig Improvement Company UK Limited
EVERTHRIVEPRP
23日前
Preci Health SA
EZDRAW
23日前
IRON REMEDY MD LLC
IRONREMEDY
23日前
Clinically Approved Holdings Pty Ltd
whywait!
23日前
SANOFI BIOTECHNOLOGY
QALBRITIX
23日前
AKROSWISS AG
NAZFOTRO
23日前
GUANGDONG KOPPLEN ELECTRONICS LIMITED
Anesinin
1か月前
UPL Limited
XYSTUS
1か月前
MicroVention, Inc.
OPAL
1か月前
Minch Global Trade Inc.
GreenPeople
23日前
C4 Therapeutics, Inc.
C4Therapeutics
23日前
Flagship Labs 84, Inc.
ETIOME
1か月前
NOVARTIS AG
23日前
NOVARTIS AG
15日前
Roche Diagnostics GmbH
COBASBOOST
15日前
Prothena Biosciences Limited
BIRCLERZI
15日前
Glanbia Nutritionals Limited
BARPRO
15日前
Novartis AG
15日前
Y-mAbs Therapeutics, Inc
SADAY-PRIT
23日前
F. Hoffmann-La Roche AG
CIMKRASVA
23日前
Novartis AG
((()))
23日前
NOVARTIS AG
((()))
23日前
Novartis AG
23日前
続きを見る